Pfizer-Mylan Pair’s Japan Generic Share at 2.8%, Aspire for Bigger Slice of Market

Albert Bourla, President and General Manager, Established Products Business Unit, Pfizer Inc. With a combined share of less than 3% in the Japanese generic market, Pfizer Japan and Mylan Seiyaku are still confident that they can boost the figure through...read more